Results 201 to 210 of about 13,126 (223)

Safety and effectiveness of adalimumab in Japanese rheumatoid arthritis patients: postmarketing surveillance report of the first 3,000 patients

Modern Rheumatology, 2012
Masayoshi Harigai, Naoki Ishiguro, Tsutomu Takeuchi   +2 more
exaly  

Guideline for postmarketing Chinese medicine pharmacoeconomic evaluation

Chinese Journal of Integrative Medicine, 2014
Zhi-Fei Wang, Xing Liao, Xie Yan-Ming
exaly  

Safety and effectiveness of adalimumab in Japanese rheumatoid arthritis patients: Postmarketing surveillance report of 7740 patients

Modern Rheumatology, 2014
Naoki Ishiguro, Tsutomu Takeuchi, Hisashi Yamanaka   +2 more
exaly  

Rivaroxaban postmarketing risk of liver injury

Journal of Hepatology, 2014
Stefan Russmann, Bruno Stieger, Gerd A Kullak-Ublick   +2 more
exaly  

Postmarketing Surveillance

2003
openaire   +1 more source

Postmarketing Evaluation

2016
openaire   +1 more source

Postmarketing surveillance evaluating the safety and effectiveness of golimumab in Japanese patients with rheumatoid arthritis

Modern Rheumatology, 2018
Shigeki Momohara, Atsushi Kawakami, Momohara Shigeki   +2 more
exaly  

Postmarketing surveillance: Statistics and augury

Journal of Chronic Diseases, 1984
openaire   +2 more sources

Postmarketing surveillance for drug safety

Clinical Pharmacology & Therapeutics, 2004
William L, Holden, Linda J, Scarazzini
openaire   +2 more sources

Postmarketing Drug Safety Surveillance Using Publicly Available Health-Consumer-Contributed Content in Social Media

ACM Transactions on Management Information Systems, 2014
Christopher C Yang, Haodong Yang, Ling Jiang   +2 more
exaly